iShares Dow Jones US Medical Dev. Stock Price, News & Analysis (BMV:IHI)

iShares Dow Jones US Medical Dev. trades on the BMV under the ticker symbol "IHI."

iShares Dow Jones US Medical Dev. declared a quarterly dividend on Monday, June 17th. Investors of record on Tuesday, June 18th will be given a dividend of $0.2533 per share on Friday, June 21st. This represents a $1.01 annualized dividend and a yield of ∞. The ex-dividend date of this dividend is Monday, June 17th. View iShares Dow Jones US Medical Dev.'s Dividend History.

News stories about IHI stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. iShares Dow Jones US Medical Dev. earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for iShares Dow Jones US Medical Dev..

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Dow Jones US Medical Dev. investors own include Shopify (SHOP), Adobe (ADBE), Cyberark Software (CYBR), iShares 20+ Year Treasury Bond ETF (TLT), salesforce.com (CRM), Veeva Systems (VEEV), Booking (BKNG), Coupa Software (COUP), IQIYI (IQ) and Micron Technology (MU).

iShares Dow Jones US Medical Dev.'s stock is owned by a number of of retail and institutional investors. Top institutional investors include Migdal Insurance & Financial Holdings Ltd. (0.00%), Assetmark Inc. (0.00%), CHURCHILL MANAGEMENT Corp (0.00%), RiverFront Investment Group LLC (0.00%), Howard Capital Management (0.00%) and Cambridge Investment Research Advisors Inc. (0.00%).

IHI stock was sold by a variety of institutional investors in the last quarter, including Ellis Investment Partners LLC, Assetmark Inc., S. R. Schill & Associates, CHURCHILL MANAGEMENT Corp, Baker Avenue Asset Management LP, RiverFront Investment Group LLC, Janney Montgomery Scott LLC and Montecito Bank & Trust.

IHI stock was purchased by a variety of institutional investors in the last quarter, including Migdal Insurance & Financial Holdings Ltd., Nelson Van Denburg & Campbell Wealth Management Group LLC, Swarthmore Group Inc., Fifth Third Securities Inc., Cambridge Investment Research Advisors Inc., Ayalon Holdings Ltd., Bank of New York Mellon Corp and Outlook Wealth Advisors LLC.

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.